It Is Disturbing, In Spite of The Existence of Appropriate Legislation, Illegal Distribution of Medicines

Volume 1 - Issue 1

Abdeen Mustafa Omer*

Received: September 17, 2018;   Published: September 25, 2018

DOI: 10.32474/LOJPCR.2018.01.000104

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

The strategy of price liberalisation and Privatization had been implemented in Sudan over the last decade and has had a positive result on government deficit. The investment law approved recently has good statements and rules on the above strategy in particular to pharmacy regulations. Under the pressure of the new privatization policy, the government introduced radical changes in the pharmacy regulations. To improve the effectiveness of the public pharmacy, resources should be switched towards areas of need, reducing inequalities and promoting better health conditions. Medicines are financed either through cost sharing or full private. The role of the private services is significant. A review of reform of financing medicines in Sudan is given in this study. Also, it highlights the current drug supply system in the public sector, which is currently responsibility of the Central Medical Supplies Public Corporation (CMS). In Sudan, the researchers did not identify any rigorous evaluations or quantitative studies about the impact of drug regulations on the quality of medicines and how to protect public health against counterfeit or low-quality medicines, although it is practically possible. However, the regulations must be continually evaluated to ensure the public health is protected against by marketing high quality medicines rather than commercial interests, and the drug companies are held accountable for their conduct.

Keywords: Counterfeits Medicines; Drug Importers; Quality of Medicines; Regulatory Authorities

Abbreviations: CMSPO: Central Medical Supplies Public Organization; CRC: Centre of Regulation and Competition; DAP: Drug Action Programme; DOP: Department of Pharmacy; FGDOP: Federal General Directorate of Pharmacy; FMOH: Federal Ministry of Health; FPPB: Federal Pharmacy and Poison Board; GMP: Good Manufacturing Practice; KS: Khartoum State; MOAR: Ministry of Animal Resources; MOH: Ministry of Health; NGOs: Non-Governmental Organizations; NDP: National Drug Policy; RDFs: Revolving Drug Funds; SPSS: Statistical Package for Social Sciences; UK: United Kingdom; USA: United States of America; WHO: World Health Organization.

Abstract| Introduction| Aims and Objectives| Medicines Legislation Framework in Sudan| Sudan Medicines’ Quality Measures| Registration of Medicines| Licensing of Pharmacy Premises| Commercial Private Pharmacies| People’s Pharmacies| Rational for the Research| Methodology| Result and Discussion| Medicines Supply System| Discussions| Nanomedicines| Conclusion and Recommendation| Ethical Clearance and Data Protection Consent| Research Limitations| Reliability and Validity of the Research Instrument| References|